Recent Quotes (30 days)

You have no recent quotes
chg | %

Piramal Phytocare Ltd  

(Public, BOM:532979)   Watch this stock  
Find more results for BOM: 532979
0.00 (0.00%)
Feb 23 - Close
BOM real-time data - Disclaimer
Currency in INR
Range     -
52 week 33.25 - 96.00
Open     -
Vol. 0.00
Mkt cap 1.19B
P/E     -
Div/yield     -
EPS -5.51
Shares 25.96M
Beta     -
Inst. own     -

Key stats and ratios

Q4 (Dec '17) 2017
Net profit margin -103.07% 4.60%
Operating margin -105.28% -2.35%
EBITD margin - -1.34%
Return on average assets - 3.17%
Return on average equity - 3.78%
Employees 362 -
CDP Score - -


Piramal Tower Ganpatrao Kadam Marg, Lower Parel
MUMBAI, 400013
+91-22-30467953 (Phone)
+91-22-30467855 (Fax)

Website links


Piramal Phytocare Limited, formerly Piramal Life Sciences Limited, is engaged in pharmaceutical business. The Company is engaged in the manufacturing and marketing of herbal products and other products. Its medicinal products are made from herbal extracts. It is engaged in global marketing of finished pharmaceutical dosage forms especially Proprietary Formulations, wherein the active ingredients are derived from natural sources. It offers a range of products that are developed to manage lifestyle ailments, such as diabetes, arthritis, obesity, constipation, liver damage, anxiety, sexual dysfunction, cough and cold. Its products include Sleecap capsule, Pylee capsule, Soyaklin forte capsule, Prementrid capsule, Zayata capsule, Rtunorm capsule, Khasceeze syrup, Intelimax capsule, Contudol gel, Phyleclip capsule, Contudol capsule, Sugarcare capsule, Stresscare capsule, Cardiocare capsule, Dormocare capsule, Femincare capsule and Menacare capsule. It is a part of the Piramal Group.

Officers and directors

Karthik Muralidharan Chief Financial Officer
Maneesh Sharma Company Secretary
Rajesh Laddha Non-Executive Director
Rashida Najmi Non-Executive Director
N. L. Bhatia Non-Executive Independent Director
Gautam Bhailal Doshi Non-Executive Independent Director
Age: 62